Dimitrios Maltezas
Overview
Explore the profile of Dimitrios Maltezas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dimou M, Iliakis T, Maltezas D, Bitsani A, Kalyva S, Koudouna A, et al.
Anticancer Res
. 2018 Jul;
38(7):4187-4191.
PMID: 29970548
Background/aim: Hematological malignancies are frequently complicated by secondary immunodeficiency (SID). Immunoglobulin replacement with intravenous gamma globulins (IVIg) reduces infection incidence, antibiotics' need and hospitalization days in these patients. Facilitated subcutaneous...
2.
3.
Kyrtsonis M, Sarris K, Koulieris E, Maltezas D, Nikolaou E, Angelopoulou M, et al.
Biomed Res Int
. 2014 Aug;
2014:159632.
PMID: 25162001
BLyS is involved in CLL biology and its low soluble serum levels related to a shorter time to first treatment (TFT). TACI is a BLyS receptor and can be shed...
4.
Sarris K, Maltezas D, Koulieris E, Bartzis V, Tzenou T, Sachanas S, et al.
Adv Hematol
. 2013 Nov;
2013:359071.
PMID: 24288537
Background. Serum free light chains (sFLC), the most commonly detected paraprotein in CLL, were recently proposed as useful tools for the prognostication of CLL patients. Objective. To investigate the prognostic...
5.
Maltezas D, Dimopoulos M, Katodritou I, Repousis P, Pouli A, Terpos E, et al.
Hematol Oncol
. 2012 Sep;
31(2):96-102.
PMID: 22961993
International Staging System (ISS), serum free light chain ratio (sFLCR) and lactate dehydrogenase (LDH) are well known, easily assessed independent prognostic indicators of outcome in multiple myeloma (MM). The purpose...
6.
Papanikolaou X, Kotsopoulou M, Triantafillopoulou I, Zoi A, Chatziantoniou V, Maltezas D, et al.
Ann Hematol
. 2011 Sep;
91(5):785-787.
PMID: 21881824
No abstract available.
7.
Leleu X, Koulieris E, Maltezas D, Itzykson R, Xie W, Manier S, et al.
Clin Lymphoma Myeloma Leuk
. 2011 Apr;
11(1):164-7.
PMID: 21454223
Waldenstrom's macroglobulinemia (WM) is an indolent B-cell lymphoma of the lymphoplasmacytic type accompanied by a serum IgM component. However, conventional IgM quantification lacks sensitivity, does not precisely reflect tumor burden...
8.
Kyrtsonis M, Levidou G, Korkolopoulou P, Koulieris E, Bartzi V, Maltezas D, et al.
Clin Lymphoma Myeloma Leuk
. 2011 Apr;
11(1):99-102.
PMID: 21454203
The distinction between WM and SMZL may be difficult since both entities share overlapping clinical, immunophenotypic, and histopathologic characteristics. In this context we evaluated whether CD138 expression could be added...
9.
Kyrtsonis M, Maltezas D, Tzenou T, Koulieris E, Bradwell A
Semin Hematol
. 2009 Apr;
46(2):110-7.
PMID: 19389494
Multiple myeloma (MM) patients have a highly variable disease course and survival varies from a few months to more than 10 years. Numerous prognostic factors have been identified, including age,...